In our study, pre-treatment with reparixin, a CXCR1/2 inhibitor, reduced CXCL8-induced TRIM46 expression and cancer cell invasion, further implicating the CXCL8-CXCR1/2 axis in ovarian cancer metastasis. Here, CXCL8 is linked to ovarian cancer.